Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine + adefovir vs entecavir in chronic hepatitis B
ChiCTR-OPC-16010157Phase 4Recruiting
- Sponsor
- Tianjin Second People's Hospital
- Start
- Dec 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of telbivudine, adefovir dipivoxil and entecavir in Chronic Hepatitis B (CHB) and Cirrhosis (3 arms), sponsored by Tianjin Second People's Hospital. Primary endpoints: HBV DNA, HBsAg and 5 more. Started Dec 2016; status: recruiting.
02
Drugs
telbivudineadefovir dipivoxilentecavir
03
Conditions
Chronic Hepatitis B (CHB)Cirrhosis
Beyond the preview
Go deeper on ChiCTR-OPC-16010157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16010157.